Advancing peptide synthesis & purification

Scholars and scientists worldwide trust Gyros Protein Technologies for transformational peptide synthesis solutions.

EXPLORE OUR SOLUTIONS

Driving accuracy and flexibility in peptide synthesis solutions

Manage a wide range of synthesis scales and workflows with configurations and functionality that meet your research needs.

21: https://www.gyrosproteintechnologies.com/peptides/products/purepep-chorus-peptide-synthesizer

PurePep Chorus - Modular, scalable configuration

PurePep® Chorus

Modular, scalable configuration

21: https://www.gyrosproteintechnologies.com/peptides/products/symphony-x-peptide-synthesizer

Symphony X - Functionality of 24 synthesizers in one

Symphony® X

Functionality of 24 synthesizers in one

21: https://www.gyrosproteintechnologies.com/peptides/products/purepep-sonata-plus-peptide-synthesizer

PurePep Sonata+ - Mid-pilot scale

PurePep® SONATA®+

Mid-pilot scale

WEBINAR

Transitioning From Discovery to Lead Optimization: Peptide Synthesis Applications in Modern Peptide Drug Development

View on demand
William C Blackwell III

SPEAKER:

William C Blackwell III, Director of Chemistry,
Aktis Oncology, RTP, NC

Want to replace your PS3 or Tribute for an even better successor system?
Now is the time to get a good deal and Trade-In your instrument to our newest 2-channel PurePep Chorus 2RV or 2RV with Induction Heating.

Learn more
Manage a wide range of synthesis scales and workflows with configurations and functionality that meet your research needs

“We can produce more and get results quicker while maintaining our high quality standard.”

Fueling R&D breakthroughs

Our peptide synthesizers accelerate research in some of the most critical applications in the fields of science and medicine.

Solid-phase peptide synthesis (SPPS) involves the successive addition of protected amino acid derivatives to a growing peptide chain immobilized on a solid phase, including deprotection and washing steps to remove unreacted groups and also side products.

Solid Phase Peptide Synthesis

Peptide synthesis in therapeutic & vaccine research

Therapeutics & Vaccines
Oncology researchers use peptides in the form of patient-specific neoantigen vaccines as immunotherapy cancer treatments

Oncology Peptide Therapeutics

Peptide nucleic acids (PNAs) are a class of modified peptides with a repetitive polypeptide-like backbone of N-(2-aminoethyl) glycine to which nucleic acid bases are attached with spacing analogous to the distances in native nucleic acid structures.

PNAs
Peptoids belong to a class of molecules known as peptidomimetics, the molecules that mimic the biologic interactions of peptides

Peptoids
Synthetic foldamers are artificial molecules including peptides, nucleic acids, and polysaccharides, whose monomer sequence enables them to spontaneously fold into a defined three-dimensional conformation that is stable in biological environments

Foldamers
Oligonucleotides, or short synthetic chains of nucleic acids, are a growing class of therapeutics with FDA approved therapies primarily for genetic diseases, but with many clinical studies underway for use in treating cancers

Oligos
Peptide synthesis platforms from Protein Technologies enable a wide range of biomedical research across multiple applications and at any scale

General Research

Keeping you current

Stay abreast of the latest scientific developments impacting biopharmaceutical research.

Read PurePep

5 factors to consider when choosing a peptide synthesizer

Choosing a peptide synthesizer to meet your specific needs can be a daunting task. We are here to help. 5 factors to consider when choosing a peptide synthesizer

Greener Peptide Synthesis: How to Adopt New Solvents in the Wake of DMF Restrictions

Discover how the peptide industry in Europe is adapting to new regulations on DMF, a commonly used solvent. Explore the challenges and opportunities of greener peptide synthesis and learn about promising alternatives to DMF.

Peptide Library Screenings: 5 Reasons Why Crude is Not Enough

Purified Peptide Libraries: 5 Reasons Why Crude is Not Enough

Peptide Vaccine Development and Production | PurePep Blog

Peptide-based vaccines have many advantages, including fully-defined composition with no biological contamination, and the possibility to customize.
Find our where to meet the Peptide team from Gyros Protein Technologies

Upcoming Events

Find our where to meet our team.
Learn more
Resource Library - Discover in-depth research, documentation, and references to support your work.

Resource Library

Discover in-depth research, documentation, and references to support your work.
Learn more
Ordering Information, ge pricing information, and place your order

Ordering Information

Connect with your sales representative, get pricing information, and place your order.
Learn more